マーケットレポート詳細
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
冠動脈バイパス術(CABG)の世界市場規模は2022年で102億ドル、2031年に158億ドル、市場の平均年成長率は5.1%になると予測されています。
当レポートでは、冠動脈バイパス術の市場予測-2031年、各種セグメント別市場分析(製品タイプ別、エンドユーザー別、国地域別、等)、パイプライン分析、COVID-19の影響分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
・市場規模(US$)
オンポンプCABG
オフポンプCABG
低侵襲直接CABG
従来型CABG
※(市場規模US$)
組織安定装置
心臓ポジショナー
リフレクター
カニューレ
心肺バイパス装置
内視鏡下血管採取システム
その他
※(市場規模US$)
従来の血管採取法
内視鏡下血管採取法 (EVH)
※(市場規模US$)
病院
循環器クリニック
研究/学術機関
※(市場規模US$)
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
市場ダイナミクス(促進要因、障壁、機会)
パイプライン分析
COVID-19の影響分析
競合状況
市場シェア分析
SWOT分析
Medtronic Plc
テルモ株式会社
KARL STORZ GmbH & Co. KG
Sorin Group (LivaNova PLC)
Boston Scientific
Ethicon US, LLC (Johnson & Johnson)
NeoGraft Technologies, Inc.
Edwards Lifesciences Corporation
MAQUET Holding B.V. & Co. KG
Genesee Biomedical Inc.
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Coronary Artery Bypass Graft Market Analysis and Forecast, 2017-2031
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. On-pump CABG
6.3.2. Off-pump CABG
6.3.3. Minimally Invasive Direct CABG
6.3.4. Conventional CABG
6.4. Market Attractiveness, by Product Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Device, 2017–2031
7.3.1. Tissue Stabilizers
7.3.2. Heart Positioners
7.3.3. Refractors
7.3.4. Cannulas
7.3.5. Cardiopulmonary Bypass Machines
7.3.6. Endoscopic Vessel Harvesting Systems
7.3.7. Others
7.3.8. 7.4 Market Attractiveness, by Device
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Technique, 2017–2031
8.3.1. Traditional Vessel Harvesting
8.3.2. Endoscopic Vessel Harvesting (EVH)
8.4. Market Attractiveness, by Technique
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Cardiology Clinics
9.3.3. Research & Academic Institutions
9.4. Market Attractiveness, by End-user
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. On-pump CABG
11.2.2. Off-pump CABG
11.2.3. Minimally Invasive Direct CABG
11.2.4. Conventional CABG
11.3. Market Attractiveness, by Product Type
11.4. Market Value Forecast, by Device, 2017–2031
11.4.1. Tissue Stabilizers
11.4.2. Heart Positioners
11.4.3. Refractors
11.4.4. Cannulas
11.4.5. Cardiopulmonary Bypass Machines
11.4.6. Endoscopic Vessel Harvesting Systems
11.4.7. Others
11.5. Market Attractiveness, by Device
11.6. Market Value Forecast, by Technique, 2017–2031
11.6.1. Traditional Vessel Harvesting
11.6.2. Endoscopic Vessel Harvesting (EVH)
11.7. Market Attractiveness, by Technique
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Hospitals
11.8.2. Cardiology Clinics
11.8.3. Research & Academic Institutions
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product Type
11.11.2. By Device
11.11.3. By Technique
11.11.4. By End-user
11.11.5. By Country
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. On-pump CABG
12.2.2. Off-pump CABG
12.2.3. Minimally Invasive Direct CABG
12.2.4. Conventional CABG
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Device, 2017–2031
12.4.1. Tissue Stabilizers
12.4.2. Heart Positioners
12.4.3. Refractors
12.4.4. Cannulas
12.4.5. Cardiopulmonary Bypass Machines
12.4.6. Endoscopic Vessel Harvesting Systems
12.4.7. Others
12.5. Market Attractiveness, by Device
12.6. Market Value Forecast, by Technique, 2017–2031
12.6.1. Traditional Vessel Harvesting
12.6.2. Endoscopic Vessel Harvesting (EVH)
12.7. Market Attractiveness, by Technique
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Hospitals
12.8.2. Cardiology Clinics
12.8.3. Research & Academic Institutions
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product Type
12.11.2. By Device
12.11.3. By Technique
12.11.4. By End-user
12.11.5. By Country/Sub-region
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. On-pump CABG
13.2.2. Off-pump CABG
13.2.3. Minimally Invasive Direct CABG
13.2.4. Conventional CABG
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Device, 2017–2031
13.4.1. Tissue Stabilizers
13.4.2. Heart Positioners
13.4.3. Refractors
13.4.4. Cannulas
13.4.5. Cardiopulmonary Bypass Machines
13.4.6. Endoscopic Vessel Harvesting Systems
13.4.7. Others
13.5. Market Attractiveness, by Device
13.6. Market Value Forecast, by Technique, 2017–2031
13.6.1. Traditional Vessel Harvesting
13.6.2. Endoscopic Vessel Harvesting (EVH)
13.7. Market Attractiveness, by Technique
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Hospitals
13.8.2. Cardiology Clinics
13.8.3. Research & Academic Institutions
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product Type
13.11.2. By Device
13.11.3. By Technique
13.11.4. By End-user
13.11.5. By Country/Sub-region
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. On-pump CABG
14.2.2. Off-pump CABG
14.2.3. Minimally Invasive Direct CABG
14.2.4. Conventional CABG
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Device, 2017–2031
14.4.1. Tissue Stabilizers
14.4.2. Heart Positioners
14.4.3. Refractors
14.4.4. Cannulas
14.4.5. Cardiopulmonary Bypass Machines
14.4.6. Endoscopic Vessel Harvesting Systems
14.4.7. Others
14.5. Market Attractiveness, by Device
14.6. Market Value Forecast, by Technique, 2017–2031
14.6.1. Traditional Vessel Harvesting
14.6.2. Endoscopic Vessel Harvesting (EVH)
14.7. Market Attractiveness, by Technique
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Hospitals
14.8.2. Cardiology Clinics
14.8.3. Research & Academic Institutions
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product Type
14.11.2. By Device
14.11.3. By Technique
14.11.4. By End-user
14.11.5. By Country/Sub-region
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. On-pump CABG
15.2.2. Off-pump CABG
15.2.3. Minimally Invasive Direct CABG
15.2.4. Conventional CABG
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Device, 2017–2031
15.4.1. Tissue Stabilizers
15.4.2. Heart Positioners
15.4.3. Refractors
15.4.4. Cannulas
15.4.5. Cardiopulmonary Bypass Machines
15.4.6. Endoscopic Vessel Harvesting Systems
15.4.7. Others
15.5. Market Attractiveness, by Device
15.6. Market Value Forecast, by Technique, 2017–2031
15.6.1. Traditional Vessel Harvesting
15.6.2. Endoscopic Vessel Harvesting (EVH)
15.7. Market Attractiveness, by Technique
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Hospitals
15.8.2. Cardiology Clinics
15.8.3. Research & Academic Institutions
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product Type
15.11.2. By Device
15.11.3. By Technique
15.11.4. By End-user
15.11.5. By Country/Sub-region
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Medtronic Plc
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. TERUMO CORPORATION
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. KARL STORZ GmbH & Co. KG
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Sorin Group (LivaNova PLC)
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Boston Scientific
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Ethicon US, LLC (Johnson & Johnson)
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. NeoGraft Technologies, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Edwards Lifesciences Corporation
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. MAQUET Holding B.V. & Co. KG
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Genesee Biomedical Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
Table 01: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031
Table 03: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 05: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 08: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031
Table 9: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 10: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 13: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031
Table 14: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 15: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031
Table 19: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 20: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031
Table 24: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 25: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 28: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031
Table 29: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 30: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Figure 01: Global Coronary Artery Bypass Graft Market Size (US$ Mn), by Region, 2022 and 2031
Figure 02: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by Product Type, 2022
Figure 03: Global Coronary Artery Bypass Graft Market Value Share, by Product Type, 2022
Figure 04: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by Device, 2022
Figure 05: Global Coronary Artery Bypass Graft Market Value Share, by Device, 2022
Figure 06: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by Technique, 2022
Figure 07: Global Coronary Artery Bypass Graft Market Value Share, by Technique, 2022
Figure 08: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by End-user, 2022
Figure 09: Global Coronary Artery Bypass Graft Market Value Share, by End-user, 2022
Figure 10: Global Coronary Artery Bypass Graft Market Value Share, by Region, 2022
Figure 11: Global Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast, 2017–2031
Figure 12: Global Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 13: Global Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 14: Global Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031
Figure 15: Global Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023-2031
Figure 16: Global Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031
Figure 17: Global Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023-2031
Figure 18: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by End-user, 2022
Figure 19: Global Coronary Artery Bypass Graft Market Value Share, by End-user, 2022
Figure 20: Global Coronary Artery Bypass Graft Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Coronary Artery Bypass Graft Market Attractiveness Analysis, by Region, 2023-2031
Figure 22: North America Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 23: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country, 2023–2031
Figure 24: North America Coronary Artery Bypass Graft Market Value Share Analysis, by Country, 2022 and 2031
Figure 25: North America Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 26: North America Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031
Figure 27: North America Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031
Figure 28: North America Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031
Figure 29: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 30: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031
Figure 31: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031
Figure 32: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2023–2031
Figure 33: Europe Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 34: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 35: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 37: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031
Figure 38: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031
Figure 39: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031
Figure 40: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 41: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031
Figure 42: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031
Figure 43: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2023–2031
Figure 44: Asia Pacific Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 45: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 46: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 47: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 48: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031
Figure 49: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031
Figure 50: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 52: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031
Figure 53: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031
Figure 54: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2022–2031
Figure 55: Latin America Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 56: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 57: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 58: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 59: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031
Figure 60: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031
Figure 61: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031
Figure 62: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 63: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031
Figure 64: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031
Figure 65: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2023–2031
Figure 66: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 67: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 68: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 69: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 70: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031
Figure 71: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031
Figure 72: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 74: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031
Figure 75: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031
Figure 76: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2023–2031